Table 1.
TAM-loaded-liposomes from 2008–2019 and their applications in BC.
Composition a | Physiochemical Properties b | Advantages/Remarks | Ref |
---|---|---|---|
TAM, SPC, CH, span 20 | MD = 203.5 ± 19.5 nm PI = 0.442 ± 0.03 |
|
[59] |
TAM, PEG-PEI | PS < 270 nm ZP = 40 mV |
|
[60] |
TAM, CH and lipid (DMPC and/or DSPC) | PS = 482 + 0.013 nm to 887 ± 0.336 nm Smooth surface Multilamellar, disc shaped ZP = −37.2 to −41.2 mV |
|
[62] |
TAM, Saturated SPC, phospholipid GmbH | N/A |
|
[63] |
TAM, GEM, DPPC, CH, DMPG and DSPE-MPEG 2000c | PS = 150–200 nm Surface charge = 50 mV and −30 mV |
|
[61] |
TAM, DAU, EPC, PEG2000-DSPE, CH, SRB | EE = 95% (DAU) and 90% (TAM) PS = 100 nm |
|
[64] |
TAM, Imatinib, DPPC, MPPC | EE > 70% 80% drug release with temperature-responsive behaviour (within 30 min above transition temperature 34.9 °C). |
|
[65] |
a SPC = soya phosphatidylcholine, CH = cholesterol, PEI = polyethylenimine, DMPC = dimyristoyl phosphatidylcholine, DSPC = distearoyl phosphatidylcholine, GEM = gemcitabine, DPPC = 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, DMPG = dimyristoyl phosphatidyglycerol, DSPE-MPEG-2000 = N-(Carbonylmethoxypoleythylene glycol-2000)-1,2,-diastearoyl-sn-glycero-3-phosphoethanolamine, DAU = daunorubicin, EPC = egg phosphatidylcholine, SRB = sulforhodamine B, MPPC = monopalmtoyl-2-hydroxy-sn-glycero-3-phosphocholine. b MD = mean diameter, PI = polydispersity index, PS = particle size, ZP = zeta-potential, EE = encapsulation efficiency, DL = drug loading. c Liposomal formulations were prepared by the TLE technique and the extrusion process.